This week's View discusses the key points of recent guidance from the European Heart Rhythm Association on the use of nonvitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Acute Coronary Syndrome, Anticoagulants, Arrhythmias, Cardiac, Atrial Fibrillation, Blood Coagulation Factors, Brain Ischemia, Creatinine, Cytochrome P-450 CYP3A, Factor Xa Inhibitors, Hemoglobins, Heart Failure, Hemorrhage, Geriatrics, Mitral Valve Stenosis, Myocardial Ischemia, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Primary Prevention, Renal Dialysis, Renal Insufficiency, Chronic, Stroke, Tomography, X-Ray Computed, Transcatheter Aortic Valve Replacement, Vascular Diseases, Warfarin, Thoracic Surgery, Geriatrics, Angiography, Diagnostic Imaging

< Back to Listings